TransAct Technologies (TACT) insiders gain stock through RSU conversions and awards

Rhea-AI Filing Summary

TransAct Technologies Inc. insiders reported indirect acquisitions of common stock through restricted stock unit (RSU) conversions. On February 27–March 1, 2026, RSUs previously granted under the company’s 2014 Equity Incentive Plan were exercised or converted into common shares at $0.00 per share under code M.

The transactions include RSUs issued on March 1, 2023, February 29, 2024, and February 27, 2025, each vesting 25% annually and converting to common stock on a one-for-one basis. Reported amounts include, for example, 2,850 and 1,675 common shares acquired indirectly.

The filing is made jointly by 325 Capital LLC, 325 Capital Master Fund LP, 325 Capital GP, LLC, and individuals including director Daniel M. Friedberg and Anil K. Shrivastava, who may be deemed to share pecuniary interests and beneficial ownership but each disclaims beneficial ownership except to the extent of any pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

325 CAPITAL LLC

(Last) (First) (Middle)

757 THIRD AVENUE

20TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSACT TECHNOLOGIES INC [ TACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		M		2,850	A	$0(1)	12,825	I(4)(5)(6)	See Footnotes(4)(5)(6)
Common Stock	02/28/2026		M		1,675	A	$0(2)	14,500	I(4)(5)(6)	See Footnotes(4)(5)(6)
Common Stock	03/01/2026		M		1,600	A	$0(3)	16,100	I(4)(5)(6)	See Footnotes(4)(5)(6)
Common Stock								1,011,789	I(4)(6)(7)	See Footnotes(4)(6)(7)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/27/2026		M			2,850	(1)	(1)	Common Stock	2,850	$0(1)	8,550	I(4)(5)(6)	See Footnotes(4)(5)(6)
Restricted Stock Units	(2)	02/28/2026		M			1,675	(2)	(2)	Common Stock	1,675	$0(2)	3,350	I(4)(5)(6)	See Footnotes(4)(5)(6)
Restricted Stock Units	(3)	03/01/2026		M			1,600	(3)	(3)	Common Stock	1,600	$0(3)	1,600	I(4)(5)(6)	See Footnotes(4)(5)(6)

1. Name and Address of Reporting Person^*

325 CAPITAL LLC

(Last) (First) (Middle)

757 THIRD AVENUE

20TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

FRIEDBERG DANIEL M.

(Last) (First) (Middle)

757 THIRD AVENUE

20TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Shrivastava Anil K

(Last) (First) (Middle)

757 THIRD AVENUE

20TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

325 Capital Master Fund LP

(Last) (First) (Middle)

190 ELGIN AVENUE

GEORGE TOWN

(Street)

GRAND CAYMAN E9 KY1-9008

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

325 Capital GP, LLC

(Last) (First) (Middle)

757 THIRD AVENUE

20TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Restricted Stock Units issued on February 27, 2025 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary date of the grant and converting to common stock on a one-for-one basis.

2. Restricted Stock Units issued on February 29, 2024 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary date of the grant, that have converted to common stock on a one-for-one basis.

3. Restricted Stock Units issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary date of the grant, that have converted to common stock on a one-for-one basis.

4. This Report is filed jointly by 325 Capital LLC, a Delaware limited liability company ("325"), 325 Capital Master Fund LP, a Cayman Islands exempted limited partnership ("325 Master Fund"), 325 Capital GP, LLC, a Delaware limited liability company registered as a foreign partnership in the Cayman Islands ("325 Capital GP"), Michael D. Braner, a citizen of the United States of America, Daniel M. Friedberg, a citizen of the United States of America, and Anil K. Shrivastava, a citizen of the United States of America (collectively, the "Reporting Persons"), each of whom may be deemed to have a pecuniary interest in the securities reported on this Form 4.

5. These securities are owned directly by Daniel M. Friedberg, a Managing Member of 325 who serves on the board of directors of TransAct Technologies Incorporated (the "Company"). 325 is entitled to receive all of the economic interest in securities granted to Mr. Friedberg in respect of Mr. Friedberg's service on the board of directors, and may therefore be deemed to beneficially own these securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended. 325 Capital GP is the general partner of 325 Master Fund, 325 is the investment manager to 325 Master Fund, and each of Messrs. Braner, Friedberg and Shrivastava are Managing Members of 325. As a result, all of the Reporting Persons may be deemed to beneficially own the securities owned directly by Mr. Friedberg. The other Reporting Persons may also be deemed "directors by deputization" of the Company.

6. Each of the Reporting Persons disclaims any beneficial ownership of any of these securities, except to the extent of any pecuniary interest therein.

7. These securities are owned directly by 325 Master Fund. As a result of the relationships described in Footnote (5) above, all of the Reporting Persons may be deemed to beneficially own the securities owned directly by 325 Master Fund.

	/s/ William J. DeFrances, Attorney-in-fact for 325 CAPITAL LLC	03/02/2026
	/s/ William J. DeFrances, Attorney-in-fact for FRIEDBERG DANIEL M.	03/02/2026
	/s/ William J. DeFrances, Attorney-in-fact for Shrivastava Anil K.	03/02/2026
	/s/ William J. DeFrances, Attorney-in-fact for 325 CAPITAL MASTER FUND LP	03/02/2026
	/s/ William J. DeFrances, Attorney-in-fact for 325 CAPITAL GP, LLC	03/02/2026
	/s/ William J. DeFrances, Attorney-in-fact for Braner Michael David	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did TransAct Technologies (TACT) report in this Form 4?

TransAct Technologies reported indirect acquisitions of common stock via exercises or conversions of restricted stock units at $0.00 per share. The transactions occurred between February 27 and March 1, 2026, and are coded M for derivative exercises or conversions rather than open-market trades.

Which securities were involved in the latest TransAct Technologies (TACT) insider filings?

The filing covers restricted stock units and the corresponding common stock of TransAct Technologies. RSUs granted under the 2014 Equity Incentive Plan convert to common shares on a one-for-one basis, with several thousand shares indirectly acquired through multiple M-code derivative exercise or conversion transactions.

Who are the reporting persons in the TransAct Technologies (TACT) Form 4?

Reporting persons include 325 Capital LLC, 325 Capital Master Fund LP, 325 Capital GP, LLC, and individuals Michael D. Braner, Daniel M. Friedberg, and Anil K. Shrivastava. They may be deemed to have pecuniary interests and beneficial ownership, subject to the disclaimers described in the footnotes.

How do the TransAct Technologies (TACT) RSU awards described in the filing vest?

The RSU awards referenced vest 25% annually, beginning on the first anniversary of the grant date. Grants from March 1, 2023, February 29, 2024, and February 27, 2025 were issued under the 2014 Equity Incentive Plan and convert into common stock on a one-for-one basis upon vesting.

What role does 325 Capital Master Fund LP play in the TransAct Technologies (TACT) ownership?

Certain securities are owned directly by 325 Capital Master Fund LP. Because 325 Capital GP is its general partner and 325 Capital LLC is its investment manager, all listed reporting persons may be deemed to beneficially own those securities, subject to each person’s disclaimer of beneficial ownership except for any pecuniary interest.

How are Daniel M. Friedberg’s TransAct Technologies (TACT) board compensation shares treated?

Securities granted to director Daniel M. Friedberg for board service are economically allocated to 325 Capital LLC. 325 is entitled to all economic interest in those securities, so the broader 325 Capital group may be deemed to beneficially own them, subject to the stated beneficial ownership disclaimers.